Acesso livre
Acesso livre

Farmácia/Notícias da Indústria

[Ainda não publicado] Pesquisadores afirmam que dose única de vacina contra HPV é altamente eficaz – “Resultado de estudo randomizado e controlado no Quênia traz novo ânimo para eliminar o câncer de colo de útero no mundo.”

22 Nov, 2021 | 09:23h

Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine

Conteúdos relacionados:

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs


Estudo RECOVERY | Aspirina como terapia complementar não reduziu a mortalidade em pacientes internados com COVID-19.

19 Nov, 2021 | 13:20h

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet

Comentário convidado: Studying the coagulopathy of COVID-19 – The Lancet

 

Comentário do autor no Twitter (fio – clique para saber mais)

 


Editorial | Vacinas contra COVID-19 para crianças – “Embora seja verdade que a maioria das crianças tenham doença assintomática ou leve, algumas ficarão bastante doentes e um pequeno número irá a óbito. Este é o motivo de crianças serem vacinadas contra gripe, meningite, catapora e hepatite.”

19 Nov, 2021 | 13:17h

COVID-19 vaccines for children – Science

Conteúdo relacionado: Review: Should children under 12 years of age be vaccinated against COVID-19?

 

Comentário no Twitter

 


Opinião | Com 128 vacinas contra Covid em desenvolvimento clínico, não se sabe se as aprovadas/autorizadas são as melhores.

19 Nov, 2021 | 13:09h

With 128 Covid vaccines in clinical development, we don’t know if the approved/authorized ones are the best ones – STAT


Relatório Clínico AAP | Biológicos para asma e doenças alérgicas cutâneas em crianças.

19 Nov, 2021 | 13:03h

Biologics for Asthma and Allergic Skin Diseases in Children – Pediatrics


M-A | Ferro por via intravenosa está associado com risco aumentado de infecção em comparação com ferro por via oral ou não reposição, o que deve ser equilibrado com os benefícios potenciais da redução na necessidade de transfusão sanguínea.

19 Nov, 2021 | 12:58h

Risk of Infection Associated With Administration of Intravenous Iron: A Systematic Review and Meta-analysis – JAMA Network Open

Comentário convidado: Intravenous Iron and Infection Risk—Still an Unanswered Question – JAMA Network Open

 

Comentário no Twitter

 


Revisão | Crianças com menos de 12 anos deveriam ser vacinadas contra COVID-19?

19 Nov, 2021 | 12:37h

Should children be vaccinated against COVID-19? – Archives of Disease in Childhood

 

Comentário do autor no Twitter (fio – clique para saber mais)

 


Covid: no Reino Unido, crianças só devem tomar a dose da vacina 12 semanas depois de uma infecção.

19 Nov, 2021 | 12:35h

Covid: Children told to delay jab for 12 weeks after infection – BBC

Relatório original: Joint Committee on Vaccination and Immunisation (JCVI) advice on COVID-19 vaccination in people aged 16 to 17 years: 15 November 2021


Estudo observacional mostra que as vacinas mRNA estão associadas à efetividade de 85% contra internação por Covid-19.

19 Nov, 2021 | 12:31h

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity – JAMA

Editorial: Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination – JAMA

Comentário: COVID-19 vaccines 85% effective against hospital cases but weaken over time – TCTMD

Estudo relacionado: Study compares the decline in effectiveness for Moderna, Pfizer, and Janssen vaccines and consequences for mortality.


8 questões sobre as novas pílulas da Merck e da Pfizer contra Covid.

19 Nov, 2021 | 12:28h

8 lingering questions about the new Covid pills from Merck and Pfizer – STAT

Conteúdos relacionados:

COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.

[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.

A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm.

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.